The abstract is read at the publisher; the summary is JClub's.
In 1,302 adjudicated infective endocarditis episodes among 3,448 Swiss adults with suspected IE and guideline-concordant imaging, 2023 Duke criteria raised sensitivity but left “possible” IE at 29–33%.
- Why it matters: Even after major ISCVID and ESC revisions, about one third of cases remain “possible,” creating a persistent diagnostic gray zone that limits clinical decision-making and research classification.
- What they did: This retrospective study (2014–2025) at two Swiss university hospitals used Endocarditis Team final diagnoses as the reference and applied 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC criteria to multimodality imaging.
- The result: Sensitivity increased from 63% (95% CI 60–66%) with 2015 Duke-ESC to 74% (71–76%) with 2023 Duke-ISCVID and 71% (68–73%) with 2023 Duke-ESC, while specificity fell from 72% to 59% and 66%, respectively.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.